U.S. court blocks sales of Bayer’s weed killer

U.S. court blocks sales of Bayer’s weed killer
(Reuters) – German agrochemicals group Bayer AG (BAYGn.DE) has been blocked from selling its dicamba-based weed killer in the United States after an appeals court rejected a federal regulator’s permit for the product. FILE PHOTO: A bridge is decorated with the logo of a Bayer AG, a German pharmaceutical and chemical maker in Wuppertal, Germany August 9, 2019. REUTERS/Wolfgang Rattay/File... Read More

U.S. court blocks sales of Bayer’s dicamba herbicide

U.S. court blocks sales of Bayer’s dicamba herbicide
FILE PHOTO: A bridge is decorated with the logo of a Bayer AG, a German pharmaceutical and chemical maker in Wuppertal, Germany August 9, 2019. REUTERS/Wolfgang Rattay/File Photo (Reuters) – German agrochemicals group Bayer AG has been blocked from selling its dicamba herbicide in the United States after an appeals court rejected a federal regulator’s permit for the product. The... Read More

California court hears appeal of $289 million verdict against Bayer in first Roundup cancer trial

California court hears appeal of $289 million verdict against Bayer in first Roundup cancer trial
(Reuters) – A California appeals court on Tuesday heard arguments in the first case that went to trial over allegations that Bayer AG’s glyphosate-based weed killer Roundup causes cancer, resulting in a $289 million judgment against the company. FILE PHOTO: A bridge is decorated with the logo of a Bayer AG, a German pharmaceutical and chemical maker in Wuppertal, Germany... Read More

Wall Street closes higher as recovery signs soothe protest, pandemic worries

Wall Street closes higher as recovery signs soothe protest, pandemic worries
NEW YORK (Reuters) – U.S. stocks posted gains on Monday as signs of U.S. economic recovery helped offset jitters over increasingly violent social unrest amid an ongoing pandemic and rising U.S.-China tensions. All three major stock indexes began the month with gains of less than 1% on the heels of a strong rally in May. “Certainly the pace of the... Read More

Gilead trades that made millions on COVID-19 drug news raise eyebrows

Gilead trades that made millions on COVID-19 drug news raise eyebrows
NEW YORK/WASHINGTON (Reuters) – Well-timed trades in Gilead Sciences Inc’s (GILD.O) options ahead of good news on the biopharmaceutical company’s COVID-19 drug treatment may draw regulatory scrutiny, experts said. FILE PHOTO: Gilead Sciences Inc pharmaceutical company is seen after they announced a Phase 3 Trial of the investigational antiviral drug Remdesivir in patients with severe coronavirus disease (COVID-19), during the... Read More

Trump to sign executive order on social media on Thursday: White House

Trump to sign executive order on social media on Thursday: White House
WASHINGTON (Reuters) – U.S. President Donald Trump on Wednesday threatened to regulate or shut down social media companies for stifling conservative voices, a day after Twitter attached a warning to some of his tweets prompting readers to fact check the president’s claims. Without offering evidence, Trump again accused such platforms of bias, tweeting: “Republicans feel that Social Media Platforms totally... Read More

BlackRock says voted to split CEO, chairman roles at Exxon Mobil

BlackRock says voted to split CEO, chairman roles at Exxon Mobil
FILE PHOTO: A sign for BlackRock Inc hangs above their building in New York U.S., July 16, 2018/File Photo HOUSTON (Reuters) – Top fund manager BlackRock Inc (BLK.N) on Wednesday said it cast an advisory vote in favor of an independent chairman and against the reelection of two directors at Exxon Mobil Corp (XOM.N) over the company’s approach to climate... Read More